5 completed, 2 unknown, 1 terminated. 8 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 5, Unknown 2, Terminated 1 |
Follow Latent Tuberculosis Infection: new trials by email Literature Review of Latent Tuberculosis Infection trials Research Report on Latent Tuberculosis Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein for 65-year-olds and Above Recombinant Mycobacterium Tuberculosis Fusion Protein, Purified Protein Derivative of Tuberculin - Latent Tuberculosis Infection | Phase 3 | Completed | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 780 | 2023-08-03 | 2026-04-30 |
| Risk of SDRs Under 3HP and 1HP Regimen for LTBI isoniazid and rifapentine - Latent Tuberculosis Infection | Phase 3 | Completed | National Taiwan University Hospital | 490 | 2019-09-24 | 2023-12-26 |
| Toward a Safe and Reachable Preventive Therapy for LTBI: a Multicenter Randomized Controlled Study in Taiwan Rifapentine and Isoniazid for 3 months, Isoniazid for 9 months - Latent Tuberculosis Infection | Phase 3 | Unknown | National Taiwan University Hospital | 283 | 2014-08-01 | 2016-12-15 |
| Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT Self Administered Therapy (SAT), SMS reminders, isoniazid and rifapentine - Latent Tuberculosis Infection | Phase 3 | Completed | Centers for Disease Control and Prevention | 1002 | 2012-09-01 | 2025-03-13 |
| "Efficacy and Safety of Levofloxacin vs Isoniazid in Latent Tuberculosis Infection in Liver Transplant Patients". Levofloxacin, Isoniazid - Latent Tuberculosis Infection, Infection in Solid Organ Transplant Recipients | Phase 3 | Terminated | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 68 | 2012-01-01 | 2014-08-06 |
| Rifampin Versus Isoniazid for the Treatment of Latent Tuberculosis Infection in Children (P4v9) Isoniazid, Rifampin - Latent Tuberculosis Infection | Phase 3 | Completed | McGill University | 844 | 2011-08-01 | 2017-12-19 |
| Comparing Two Preventive Regimens for Latent Tuberculosis Infection (LTBI) 4-month rifampin vs. 9-month isoniazid - Latent Tuberculosis Infection | Phase 3 | Unknown | National Taiwan University Hospital | 300 | 2011-05-01 | 2011-07-20 |
| Randomized Clinical Trial Comparing 4RIF vs. 9INH for LTBI Treatment-effectiveness Isoniazid, Rifampin - Latent Tuberculosis Infection | Phase 3 | Completed | McGill University | 6031 | 2009-08-01 | 2017-12-19 |
Latent Tuberculosis (8) · Tuberculosis (4)
Actinomycetales Infections (8) · Bacterial Infections (8) · Bacterial Infections and Mycoses (8) · Gram-Positive Bacterial Infections (8) · Infections (8) · Latent Infection (8) · Mycobacterium Infections (8) · Tuberculosis (4)
Isoniazid (7) · rifapentine (3) · Rifampin (2) · Levofloxacin (1) · Tuberculin (1)
National Taiwan University Hospital (3) · McGill University (2) · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. (1) · Centers for Disease Control and Prevention (1) · Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (1)
Taiwan (3) · Australia (2) · Benin (2) · Brazil (2) · Canada (2) · China (2) · Ghana (2) · Guinea (2) · Indonesia (2) · Spain (2) · Saudi Arabia (1) · South Africa (1) · South Korea (1) · United States (1)
Andrey S Borisov, MD, MPH (1) · Dick Menzies, MD (1) · Dick Menzies, MD, MSc (1) · Jann-Yuan Wang, MD, PhD (1) · Jann-Yuan Wang, MD. PhD. (1) · Jann-Yuan Wang, Ph.D. (1) · Robert Belknap, MD (1) · Shuihua Lu, bachelor (1)
PMID 31866327, PMID 32539440, PMID 32785709, PMID 36949623, PMID 20627913, PMID 25404412, PMID 29114781, PMID 29393655, PMID 30029896, PMID 30067928, PMID 30067931, PMID 36815322, PMID 38996972